BioSpace News Archive

Business

n-Lorem Foundation Partners with Alnylam to Expand Technology Access to RNAi Therapeutics for Patients with Nano-rare Diseases

n-Lorem, a nonprofit Foundation, discovering and providing experimental antisense oligonucleotide (ASO) medicines to nano-rare disease patients (1 to 30 patients worldwide) for free, for life, today announced a new partnership with Alnylam Pharmaceuticals Inc. (NASDAQ: ALNY).

January 18, 2022
·
5 min read
Genetown

Biofrontera Inc. Issues Letter to Shareholders Highlighting 2021 Successes and Key Elements of the Strategic Plan for 2022 and Beyond

Biofrontera Inc., a biopharmaceutical company specializing in the commercialization of dermatological products, issued the following letter from CEO Erica Monaco and Executive Chairman of the Board Hermann Lübbert.

January 18, 2022
·
9 min read
Pharm Country

SOLTIVE™ SuperPulsed Laser System shortens kidney stone procedure time, proves more cost-effective than Holmium: YAG, abstracts show

Olympus today announced abstract findings of independent clinical studies that show the treatment of kidney stones with the SOLTIVE™ Premium SuperPulsed Laser System (SOLTIVE Laser System) may offer the potential for shorter procedure times, better patient outcomes and lower procedures costs than those performed with Holmium: YAG.

January 18, 2022
·
5 min read
Business

Positron Enters Long Term Cooperation Agreement with Neusoft Medical Systems for the Development and Distribution of Positron’s State of the Art PET/CT System in North America

Positron Corporation (“Positron” or the “Company”) (OTC: POSC), is pleased to announce today that the Company has entered into a strategic business relationship with Neusoft Medical Systems for manufacturing, distribution, and continued R&D advancements of Positron’s new PET/CT nuclear imaging device.

January 18, 2022
·
4 min read
Business

The Well Told Company Announces Promotion of Betty Au Yeung, CPA, CGMA, to Position of CFO and Corporate Secretary

Prior to joining Well Told, Betty gained experience at Deloitte, Bell, Rogers, BGIS as well as an accountant consultancy focused on start-ups.

January 18, 2022
·
2 min read
Pharm Country

Kidney Disease Experts Support Standardization of Measuring Blood Pressure and Other 2021 Guidelines

The National Kidney Foundation’s work group of kidney disease experts released their commentary in the American Journal of Kidney Diseases regarding the latest clinical guidelines for managing blood pressure in people with chronic kidney disease.

January 18, 2022
·
4 min read
Dual Chamber Prefilled Syringes Market To Reach USD 223.3 Million By 2028, Says Reports And Data

Growing demand for advanced devices to provide controlled drugs is a significant factor influencing growth of the market.

January 18, 2022
·
6 min read
Protein Crystallization & Crystallography Market Size to Reach USD 2.23 Billion in 2028, Says Reports And Data

Increasing demand for protein therapeutics and rising investment to accelerate proteomics research are key factors driving revenue growth of the market.

January 18, 2022
·
8 min read
Antimicrobial Susceptibility Testing/Antibiotic Sensitivity Testing Market Size to Reach USD 4,821.04 Million in 2028 Growing at a CAGR of 5.1%

According to Emergen Research, the global antimicrobial susceptibility testing/antibiotic sensitivity testing market size was USD 3,226.04 million in 2020 and is expected to reach USD 4,821.04 million in 2028 and register a revenue CAGR of 5.1% during the forecast period, 2021-2028.

January 18, 2022
·
8 min read
Interventional Oncology Devices Market Size to Reach USD 3.11 Billion in 2027 Growing at a CAGR of 6.6%

According to Emergen Research, the global interventional oncology devices market size was USD 1.92 billion in 2019 and is expected to reach USD 3.11 Billion in 2027 and register a revenue CAGR of 6.6% during the forecast period, 2020-2027.

January 18, 2022
·
7 min read